First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

por Wei, Guoqing, Rafiyath, Shamudheen, Liu, Delong
Publicado 2010

Recent advances and novel agents for gastrointestinal stromal tumor (GIST)

por Lamba, Gurpreet, Ambrale, Samir, Lee, Byung, Gupta, Ridhi, Rafiyath, Shamudheen M, Liu, Delong
Publicado 2012

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

por Rafiyath, Shamudheen M, Rasul, Mohammad, Lee, Byung, Wei, Guoqing, Lamba, Gurpreet, Liu, Delong
Publicado 2012